Back to Articles
OncologyReview Article

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

6 July 2026·2 min read·Journal of drugs in dermatology : JDD

Abstract / Summary

Though basal cell carcinoma (BCC) is most often studied in Fitzpatrick Skin Types (FST) I-III, BCC in skin of color (SOC) is characterized by unique clinical features and a propensity toward pigmentation. While cutaneous malignancy occurs with decreased frequency in FST IV - VI, the diagnosis is generally associated with disproportionately increased morbidity and mortality. Accordingly, it is increasingly vital for dermatologists to recognize clinical presentations of skin cancer in individuals with SOC to improve outcomes and mitigate gaps in care. We systematically reviewed the literature regarding pigmented basal cell carcinoma (pBCC) in individuals with SOC. The keywords “pigmented basal cell carcinoma” and “pBCC” were independently combined with “Asian,” “Black,” “Hispanic,” “Latinx,” “skin of color,” and “SOC” to perform a PubMed/MEDLINE search. Based on the selected search terms, 26 unique articles were identified. Of these, 16 articles met the inclusion criteria for full-text screening. Pigmented BCC is more common in those with SOC and can be clinically challenging to diagnose. As evidence suggests that pBCC confers a favorable prognosis, efforts to standardize reporting and formalize sub-classification should be considered. Furthermore, as the existing literature is primarily retrospective with small sample sizes, larger prospective studies would be valuable additions to the literature and aid in shedding light on disparate outcomes associated with cutaneous malignancy in skin of color.

Topics

HumansBasal Cell CarcinomaSkin NeoplasmsSkin Pigmentation

Primary Source

Journal of drugs in dermatology : JDD

View Source

Ask Prognia AI

Have questions about this review article?

Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.

Related Clinical Guidelines